17th Chiva annual conference

Oral Abstract Presentations

1. High-risk HPV prevalence and serostatus in women living with perinatally acquired HIV (the SHiP study)
Merle Henderson1,2*, Tamara Elliott1,2*, Ellie Crook2, Sara Ayres2, Simon Beddows3, Kavita Panwar3, Corrina Wright4,5, Deirdre Lyons2, Miranda Cowen2, Hasit Patel5, David Smith5, Sarah Fidler1,2, Caroline Foster2
1Department of Infection, Imperial College London, 2Imperial College Healthcare NHS Trust, 3HPV Unit, UK Health Security Agency, 4North West London Pathology, 5Cervical Screening London, Health Service Laboratories
*joint first author

2. Population-level paediatric HIV surveillance in England: the current picture
Gabriela Toledo1, Kate Francis1, Sally Cavanagh2 ,Anna Kafkalias2 ,Claire Thorne1, Helen Peters1

1Children’s HIV and AIDS Reporting System, UCL Great Ormond Street Institute of Child Health, London UK, 2NHS England

3. Infant Postnatal Prophylaxis (PNP) following maternal viraemia during breastfeeding
Dr Emily A Lees1&2, Mr Neil Tickner3, Dr Hermione Lyall3, Dr Paddy McMaster4, Dr Birgitte Smith5, Dr Lucy Cliffe6, Dr Caroline Foster3

1 University of Oxford, Oxford Children’s Hospital, Oxford, UK, 2 Fitzwilliam College, University of Cambridge, Cambridge, UK, 3 Imperial College Healthcare NHS Trust, St Mary’s Hospital, London, UK, 4 Manchester University NHS Foundation Trust, North Manchester General Hospital,
Manchester, UK, 5 Hvidovre Hospital, Copenhagen University Hospital, Hvidovre, Denmark
6 Nottingham University NHS Foundation Trust, Nottingham Children’s Hospital, Nottingham, UK

Posters

Please see below the posters submitted to our 2023 annual conference.

1. The HIV empowering adults’ decisions to share – UK/Uganda project (HEADS-UP): Primary outcomes
Michael Evangeli – Royal Holloway University of London

2. The HIV empowering adults’ decisions to share – UK/Uganda project (HEADS-UP): A qualitative analysis of interviews with participants and therapists
Michael Evangeli – Royal Holloway University of London

3. Metabolic health and bone density in youth living with perinatal HIV
Caroline Foster, Colette Smith, Merle Henderson, Moira Cheung, Sarah Fidler – Imperial College London

4. The BONDY Study: Bone density in youth living with perinatally acquired HIV
Merle Henderson1,2, Colette Smith3, Sarah Fidler1,2, Moira Cheung4, Caroline Foster2,5

1Department of Infectious Disease, Faculty of Medicine, St Mary’s Campus, Imperial College London UK, 2Department of HIV and GU Medicine, St Mary’s Hospital, Imperial College Healthcare NHS Trust, London UK, 3Department of Population Health Sciences UCL Institute for Global Health, London UK, 4Department of Paediatrics, Evelina London Children’s Hospital, Guys and St Thomas’ NHS Trust, London UK, 5Department of Paediatric Infectious Diseases, St. Mary’s Hospital, Imperial College Healthcare NHS Trust, London UK

5. Eligibility for long acting cabotegravir/ rilpivirine in youth aged 12-25 living with perinatally-acquired HIV
Fionnuala Ryan1, Nicola E Mackie2, Hana Jayadel1, Sara Ayers2, Caroline Foster1,2

1Department of Paediatric Infectious Diseases, Imperial College Healthcare NHS Trust, 2Department of GUM/HIV Medicine, Imperial College Healthcare NHS Trust

6. Comparison of pregnancy outcomes for mothers living with perinatally acquired HIV, behaviourally acquired HIV, and those not living with HIV
S Shah, GP Taylor, EGH Lyall, C Foster – Imperial College Healthcare NHS Trust

7. Correlation of HIV-Coinfection with Severe Malaria in Children: A Systematic Review and Meta-Analysis
Ni Made Adnya Suasti – University of Oxford